BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32271417)

  • 1. Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy.
    De Dosso S; Nucifora M; Sahnane N; Epistolio S; Riveiro ME; Bertolini V; Bucci E; Boldorini R; Freguia S; Frattini M; Saletti P
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2994-3003. PubMed ID: 32271417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer.
    Jiang W; Wang H; Dong X; Yu X; Zhao Y; Chen D; Yan B; Cheng J; Zhuo S; Wang H; Yan J
    JAMA Surg; 2024 May; 159(5):519-528. PubMed ID: 38416471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).
    Lee S; Ma C; Shi Q; Meyers J; Kumar P; Couture F; Kuebler P; Krishnamurthi S; Lewis D; Tan B; O'Reilly EM; Shields AF; Meyerhardt JA
    Br J Cancer; 2023 Aug; 129(2):283-290. PubMed ID: 37179438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for asymptomatic recurrence in resected stage III colon cancer: does it result in a more favorable outcome?
    Smoragiewicz M; Lim H; Peixoto RD
    J Gastrointest Oncol; 2015 Jun; 6(3):268-73. PubMed ID: 26029453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for stage II and III gastric adenocarcinoma: A retrospective analysis with long-term follow-up.
    Wang HT; Chiu CF; Yang HR; Jeng LB; Bai EJ; Chen TH; Yeh CC; Chu CL; Bai LY
    J Formos Med Assoc; 2024 May; ():. PubMed ID: 38719675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer.
    Collienne M; Arnold D
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection (IOCCRC): a randomized, multicenter, prospective, phase III trial.
    Zhang RX; Wu XJ; Wan DS; Lin JZ; Ding PR; Liao LE; Lei J; Lu ZH; Li LR; Chen G; Kong LH; Wang FL; Zhang J; Fan WH; Jiang W; Zhou WH; Li C; Li Y; Li XY; Peng JH; Pan ZZ
    Int J Surg; 2024 Apr; ():. PubMed ID: 38652147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.
    Lin A; Zhang H; Hu X; Chen X; Wu G; Luo P; Zhang J
    Pharmacol Res; 2020 Sep; 159():105028. PubMed ID: 32569820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique.
    Wang RQ; Chen CJ; Jing Y; Qin JY; Li Y; Chen GF; Zhou W; Li YH; Wang J; Li DW; Zhao HM; Wang BH; Wang LL; Wang H; Wang MZ; Gao XN; Yu L
    Cancer Med; 2020 Nov; 9(22):8457-8467. PubMed ID: 32970934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis.
    Dai D; Wang Y; Zhu L; Jin H; Wang X
    PeerJ; 2020; 8():e9149. PubMed ID: 32547859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data.
    Kim N; Kim SH; Kang SG; Moon JH; Cho J; Suh CO; In Yoon H; Chang JH
    Radiat Oncol; 2020 Jul; 15(1):184. PubMed ID: 32736562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, Randomized, Phase III Trial of Neoadjuvant Chemoradiation With Capecitabine and Irinotecan Guided by
    Zhu J; Liu A; Sun X; Liu L; Zhu Y; Zhang T; Jia J; Tan S; Wu J; Wang X; Zhou J; Yang J; Zhang C; Zhang H; Zhao Y; Cai G; Zhang W; Xia F; Wan J; Zhang H; Shen L; Cai S; Zhang Z
    J Clin Oncol; 2020 Dec; 38(36):4231-4239. PubMed ID: 33119477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the landscape of colorectal cancer using targeted deep sequencing.
    Lee CS; Song IH; Lee A; Kang J; Lee YS; Lee IK; Song YS; Lee SH
    Sci Rep; 2021 Apr; 11(1):8154. PubMed ID: 33854094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.
    Zaidi SH; Harrison TA; Phipps AI; Steinfelder R; Trinh QM; Qu C; Banbury BL; Georgeson P; Grasso CS; Giannakis M; Adams JB; Alwers E; Amitay EL; Barfield RT; Berndt SI; Borozan I; Brenner H; Brezina S; Buchanan DD; Cao Y; Chan AT; Chang-Claude J; Connolly CM; Drew DA; Farris AB; Figueiredo JC; French AJ; Fuchs CS; Garraway LA; Gruber S; Guinter MA; Hamilton SR; Harlid S; Heisler LE; Hidaka A; Hopper JL; Huang WY; Huyghe JR; Jenkins MA; Krzyzanowski PM; Lemire M; Lin Y; Luo X; Mardis ER; McPherson JD; Miller JK; Moreno V; Mu XJ; Nishihara R; Papadopoulos N; Pasternack D; Quist MJ; Rafikova A; Reid EEG; Shinbrot E; Shirts BH; Stein LD; Teney CD; Timms L; Um CY; Van Guelpen B; Van Tassel M; Wang X; Wheeler DA; Yung CK; Hsu L; Ogino S; Gsur A; Newcomb PA; Gallinger S; Hoffmeister M; Campbell PT; Thibodeau SN; Sun W; Hudson TJ; Peters U
    Nat Commun; 2020 Jul; 11(1):3644. PubMed ID: 32686686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
    Pfister D; Núñez NG; Pinyol R; Govaere O; Pinter M; Szydlowska M; Gupta R; Qiu M; Deczkowska A; Weiner A; Müller F; Sinha A; Friebel E; Engleitner T; Lenggenhager D; Moncsek A; Heide D; Stirm K; Kosla J; Kotsiliti E; Leone V; Dudek M; Yousuf S; Inverso D; Singh I; Teijeiro A; Castet F; Montironi C; Haber PK; Tiniakos D; Bedossa P; Cockell S; Younes R; Vacca M; Marra F; Schattenberg JM; Allison M; Bugianesi E; Ratziu V; Pressiani T; D'Alessio A; Personeni N; Rimassa L; Daly AK; Scheiner B; Pomej K; Kirstein MM; Vogel A; Peck-Radosavljevic M; Hucke F; Finkelmeier F; Waidmann O; Trojan J; Schulze K; Wege H; Koch S; Weinmann A; Bueter M; Rössler F; Siebenhüner A; De Dosso S; Mallm JP; Umansky V; Jugold M; Luedde T; Schietinger A; Schirmacher P; Emu B; Augustin HG; Billeter A; Müller-Stich B; Kikuchi H; Duda DG; Kütting F; Waldschmidt DT; Ebert MP; Rahbari N; Mei HE; Schulz AR; Ringelhan M; Malek N; Spahn S; Bitzer M; Ruiz de Galarreta M; Lujambio A; Dufour JF; Marron TU; Kaseb A; Kudo M; Huang YH; Djouder N; Wolter K; Zender L; Marche PN; Decaens T; Pinato DJ; Rad R; Mertens JC; Weber A; Unger K; Meissner F; Roth S; Jilkova ZM; Claassen M; Anstee QM; Amit I; Knolle P; Becher B; Llovet JM; Heikenwalder M
    Nature; 2021 Apr; 592(7854):450-456. PubMed ID: 33762733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
    Koemans WJ; van der Kaaij RT; Wassenaar ECE; Boerma D; Boot H; Sikorska K; Los M; Grootscholten C; Hartemink KJ; Veenhof AAFA; Kodach L; Snaebjornsson P; van Sandick JW
    J Surg Oncol; 2021 Mar; 123(4):904-910. PubMed ID: 33428786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
    Wang W; Wang H; Xiang L; Ni T; Jin F; Deng J; Zhang Y; Shintaro I; Zhou Y; Liu Y
    Oncol Rep; 2020 Jul; 44(1):77-90. PubMed ID: 32627002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors.
    Cao Q; Zhou DJ; Pan ZY; Yang GG; Zhang H; Ji LN; Mao ZW
    Angew Chem Int Ed Engl; 2020 Oct; 59(42):18556-18562. PubMed ID: 32557982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
    Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China.
    Lv W; Cheng H; Shao D; Wei Y; Zhu W; Wu K; Jiang W; Hu L; Sha Z; Zhong B; Pei X
    Front Oncol; 2021; 11():630717. PubMed ID: 33777783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.